Indication
Staphylococcus chronic bronchitis
Staphylococcus chronic bronchitis refers to a lower respiratory tract infection or bacterial exacerbation of chronic bronchitis driven by *Staphylococcus* species, most commonly *Staphylococcus aureus*. Read more about Staphylococcus chronic bronchitis
25 drugs 23 manufacturers
Drugs that treat it
Common Staphylococcus chronic bronchitis therapies.
MOXIFLOXACIN HCL
MOXIFLOXACIN HCL
MOXIFLOXACIN (moxifloxacin HCl in sodium acetate and sulfate,water,iso-osm)
MOXIFLOXACIN HCL
MOXIFLOXACIN HCL
MOXIFLOXACIN HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonStaphylococcus chronic bronchitis refers to a lower respiratory tract infection or bacterial exacerbation of chronic bronchitis driven by *Staphylococcus* species, most commonly *Staphylococcus aureus*.
This condition primarily affects adults with underlying chronic obstructive pulmonary disease or preexisting airway architecture damage, such as bronchiectasis.
Pathophysiologically, persistent mucosal inflammation, goblet cell hyperplasia, and impaired mucociliary clearance facilitate staphylococcal colonization and invasion of the bronchial mucosa.
It is clinically characterized by a baseline productive cough that worsens acutely with increased sputum volume, enhanced sputum purulence, and progressive dyspnea.
- nih.gov
Staphylococcus chronic bronchitis refers to a lower respiratory tract infection or bacterial exacerbation of chronic bronchitis driven by *Staphylococcus* species, most commonly *Staphylococcus aureus* Pathophysiologically, persistent mucosal inflammation, goblet cell hyperplasia, and impaired mucociliary clearance facilitate staphylococcal colonization and invasion of the bronchial mucosa It is clinically characterized by a baseline productive cough that worsens acutely with increased sputum vo...
- nih.gov
Staphylococcus chronic bronchitis refers to a lower respiratory tract infection or bacterial exacerbation of chronic bronchitis driven by *Staphylococcus* species, most commonly *Staphylococcus aureus*
- fda.gov
This condition primarily affects adults with underlying chronic obstructive pulmonary disease or preexisting airway architecture damage, such as bronchiectasis
- nih.gov
This condition primarily affects adults with underlying chronic obstructive pulmonary disease or preexisting airway architecture damage, such as bronchiectasis
- ersnet.org
This condition primarily affects adults with underlying chronic obstructive pulmonary disease or preexisting airway architecture damage, such as bronchiectasis
- ersnet.org
Pathophysiologically, persistent mucosal inflammation, goblet cell hyperplasia, and impaired mucociliary clearance facilitate staphylococcal colonization and invasion of the bronchial mucosa
- nih.gov
It is clinically characterized by a baseline productive cough that worsens acutely with increased sputum volume, enhanced sputum purulence, and progressive dyspnea
Personalize your experience
Follow Staphylococcus chronic bronchitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.